Expert Ratings for Beauty Health
Portfolio Pulse from Benzinga Insights
Beauty Health (NASDAQ:SKIN) has received mixed analyst ratings in the last quarter with 2 bullish, 1 indifferent, and 1 somewhat bearish rating. The average 12-month price target among 4 analysts is $9.38, with a high of $23.00 and a low of $2.00. This target is a 14.73% decrease from the previous target of $11.00. Analyst ratings are opinions based on financial analysis and are updated quarterly.
November 14, 2023 | 12:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Beauty Health has a current average analyst price target of $9.38, which is a decrease of 14.73% from the previous target. The ratings are mixed, with 2 bullish and 1 somewhat bearish in the last quarter.
The mixed analyst ratings with a decreased price target suggest uncertainty and a lack of consensus about the company's future performance. This could lead to neutral short-term impact on the stock as investors digest the varied opinions.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100